We could not find any results for:
Make sure your spelling is correct or try broadening your search.
Alpha Cognition Inc. (Nasdaq: ACOG) (“Alpha Cognition”, or the “Company”), a biopharmaceutical company committed to developing novel therapies for debilitating neurodegenerative disorders, today...
Alpha Cognition Inc. (NASDAQ: ACOG) (“Alpha Cognition”, or the “Company”), announces that in connection with the Company’s listing on the Nasdaq Capital Market the Company will voluntarily delist...
Alpha Cognition Inc. (Nasdaq: ACOG) (CSE: ACOG) (“Alpha Cognition” [ACI], or the “Company”), a biopharmaceutical company developing novel therapies for debilitating neurodegenerative disorders...
Alpha Cognition Inc. (NASDAQ: ACOG) (CSE: ACOG) (“Alpha Cognition”, or the “Company”), a biopharmaceutical company developing novel therapeutics for debilitating neurodegenerative disorders...
Alpha Cognition Inc. (Nasdaq: ACOG) (CSE: ACOG) (“Alpha Cognition”, or the “Company”), a biopharmaceutical company committed to developing novel therapies for debilitating neurodegenerative...
Period | Change | Change % | Open | High | Low | Avg. Daily Vol | VWAP | |
---|---|---|---|---|---|---|---|---|
1 | 0.03 | 0.6 | 5 | 5.7 | 4.82 | 90450 | 5.19604732 | CS |
4 | -0.81 | -13.8698630137 | 5.84 | 6.98 | 4.66 | 120751 | 5.78932196 | CS |
12 | -1.97 | -28.1428571429 | 7 | 7 | 4.66 | 119047 | 5.75418356 | CS |
26 | -1.97 | -28.1428571429 | 7 | 7 | 4.66 | 119047 | 5.75418356 | CS |
52 | -1.97 | -28.1428571429 | 7 | 7 | 4.66 | 119047 | 5.75418356 | CS |
156 | -1.97 | -28.1428571429 | 7 | 7 | 4.66 | 119047 | 5.75418356 | CS |
260 | -1.97 | -28.1428571429 | 7 | 7 | 4.66 | 119047 | 5.75418356 | CS |
It looks like you are not logged in. Click the button below to log in and keep track of your recent history.
Support: 1-888-992-3836 | support@advfn.com
By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions